Nektar Therapeutics [NASDAQ: NKTR] stock went on a downward path that fall over -9.40% on Wednesday, amounting to a one-week price increase of more than 4.65%. Over the last 12 months, NKTR stock rose by 37.32%. The one-year Nektar Therapeutics stock forecast points to a
Nektar Therapeutics [NASDAQ: NKTR] closed the trading session at $1.29. The company report on March 22, 2024 at 2:00 PM that Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference. Nektar Therapeutics (Nasdaq: NKTR) management is scheduled to
Nektar Therapeutics [NASDAQ: NKTR] gained 9.47% on the last trading session, reaching $1.04 price per share at the time. The company report on March 22, 2024 at 2:00 PM that Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual
Nektar Therapeutics [NASDAQ: NKTR] jumped around 0.12 points on Monday, while shares priced at $0.90 at the close of the session, up 15.38%. The company report on March 4, 2024 at 4:15 PM that Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results. Nektar
© 2024, Powered by Smart TechOne
